Here’s a breakdown of the provided text, highlighting the key information:
Main Announcement:
Oncorad Group achieves a critically important scientific milestone: For the first time, an African oncology center has published a research article in the prestigious American review Advances in radiation Oncology.
The Research:
Topic: Combined treatment of prostate cancer using high-Flow dose (HDR) brachytherapy and external radiotherapy.
Location of Research: Oncorad Group’s research unit at the Casablanca Littoral clinic.
Importance: This publication represents unprecedented international recognition of Moroccan expertise in radiotherapy. The study’s quality and results were praised and deemed comparable to those in advanced countries.
Study Details:
Involved over 120 patients with aggressive prostate cancer.
Demonstrated the effectiveness of the combined protocol.
Achieved a remission rate of 92%.
Reported an absence of relevant toxicity.
The protocol is already a reference treatment in industrialized countries, and it’s submission in Morocco yielded convincing results.
Largest African Series: this is the largest clinical series published to date in Africa and the region concerning this therapeutic approach. International Collaboration: The study included several dozen foreign patients, underscoring the transnational nature of the work and positioning Oncorad Group as a leading regional medical player.
The Team:
Moroccan Researchers and Clinicians:
Pr Redouane Samlali (Founder of Oncorad Group)
Dr. Hamza Samlali (Main Investigator)
Dr. najlaa Assaid (Scientific Coordinator)
Medical Physicists: Youness Khobbaizi, Omar Hanicha, Mahdi Abou El Houda, Sanaa Nabil.
Scientific Support:
Pr Hassan Jouhadi (Professor at the Faculty of Medicine of Casablanca, Head of Oncology Department at CHU Casablanca, and leader of academic research teams).
Oncorad Group’s research Unit:
Structure: A multidisciplinary unit comprising oncologists, medical physicists, and researchers.
Mission: Committed to developing innovative protocols adapted to local realities, serving as a strategic lever for continuous improvement in cancer management in Morocco.
Future Projects: Currently working on robot-assisted surgery,advanced radiotherapy techniques,and the genetic and biological aspects of cancer.
Approach: Collaborative, with a network of national and international partners, making it a dynamic research platform.About Advances in Radiation Oncology:
Publisher: Elsevier, in collaboration with the American Society for Radiation Oncology (ASTRO).
status: A world reference in the field.
Metrics: Impact factor of 2.7.
Indexing: Indexed in major scientific databases (Pubmed Central, Scopus, Web of Science, etc.).
Focus: Values clinical work with high impact, particularly in resource-limited contexts.
Broader Impact:
Harmonization of Strategies: By contributing african data to international scientific literature,Oncorad Group is laying the groundwork for harmonizing cancer treatment strategies nationally and regionally.
First Milestone: This publication represents a significant first step.
In essence,the article celebrates a major achievement for Moroccan and african oncology,showcasing the quality of research and clinical practice at Oncorad Group and its contribution to global scientific knowledge.
